BDBM50510102 CHEMBL4445289

SMILES: CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12

InChI Key: InChIKey=XBCNZHWPHYJZGM-IBGZPJMESA-N

Data: 3 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50510102   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50510102 (CHEMBL4445289) Show SMILES CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C22H26N2O3/c1-22(2,13-12-15-6-4-3-5-7-15)23-14-19(26)16-8-10-18(25)21-17(16)9-11-20(27)24-21/h3-11,19,23,25-26H,12-14H2,1-2H3,(H,24,27)/t19-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	21	n/a	n/a	n/a	n/a
Shenyang Pharmaceutical University Curated by ChEMBL					Assay Description Agonist activity at human beta2 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay				Bioorg Med Chem 27: 2306-2314 (2019) Article DOI: 10.1016/j.bmc.2018.10.043
					More data for this Ligand-Target Pair
Beta-1 adrenergic receptor (Homo sapiens (Human))	BDBM50510102 (CHEMBL4445289) Show SMILES CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C22H26N2O3/c1-22(2,13-12-15-6-4-3-5-7-15)23-14-19(26)16-8-10-18(25)21-17(16)9-11-20(27)24-21/h3-11,19,23,25-26H,12-14H2,1-2H3,(H,24,27)/t19-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	1.00E+4	n/a	n/a	n/a	n/a
Shenyang Pharmaceutical University Curated by ChEMBL					Assay Description Agonist activity at human beta1 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay				Bioorg Med Chem 27: 2306-2314 (2019) Article DOI: 10.1016/j.bmc.2018.10.043
					More data for this Ligand-Target Pair
Beta-2 adrenergic receptor (Homo sapiens (Human))	BDBM50510102 (CHEMBL4445289) Show SMILES CC(C)(CCc1ccccc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r| Show InChI InChI=1S/C22H26N2O3/c1-22(2,13-12-15-6-4-3-5-7-15)23-14-19(26)16-8-10-18(25)21-17(16)9-11-20(27)24-21/h3-11,19,23,25-26H,12-14H2,1-2H3,(H,24,27)/t19-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	n/a	n/a	0.0209	n/a	n/a	n/a	n/a
Shenyang Pharmaceutical University Curated by ChEMBL					Assay Description Agonist activity at human beta2 adrenergic receptor expressed in HEK293 cells assessed as increase in cAMP accumulation after 60 mins by HTRF assay				Bioorg Med Chem 27: 2306-2314 (2019) Article DOI: 10.1016/j.bmc.2018.10.043
					More data for this Ligand-Target Pair